Better Context → Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

novo cover image

Posted in: Basal Insulin, GLP-1RA May 03 | 2019Tresiba Hypo Benefit Over Toujeo; Novo Q1 '19 Earnings Update Purchase Blast

insulet cover image

Posted in: Insulin Delivery May 02 | 2019Insulet Q1 '19 Earnings Update Purchase Blast

dexcom cover image

Posted in: Glucose Monitoring May 01 | 2019Dexcom Q1 '19 Earnings Update Purchase Blast

lexicon cover image

Posted in: SGLT2i May 01 | 2019No Update on Sota CRL Resolution Timeline; Lexicon Q1 '19 Earnings Update Purchase Blast

tandem cover image

Posted in: Insulin Delivery Apr 30 | 2019Tandem Q1 '19 Earnings Update Purchase Blast

merck and pfizer cover image

Posted in: DPP-IVi, GLP-1RA, SGLT2i Apr 30 | 2019Merck and Pfizer Q1 '19 Earnings Updates Purchase Blast

lilly cover image

Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, Glucose Monitoring, Insulin Delivery, SGLT2i Apr 30 | 2019REWIND Filed; Empa T1DM, Nasal Glucagon Delayed; Lilly Q1 '19 Earnings Update Access Free Blast

novo cover image

Posted in: GLP-1RA Apr 29 | 2019Victoza Pediatric Trial (ELLIPSE) Results and Regulatory Filings Purchase Blast

biocon cover image

Posted in: Basal Insulin, Bolus Insulin Apr 26 | 2019Biocon CY Q1 '19 (FY Q4 '19) Earnings Update Purchase Blast

lexicon and sanofi cover image

Posted in: SGLT2i Apr 26 | 2019Zynquista Approved in EU for T1DM Purchase Blast

lilly cover image

Posted in: Bolus Insulin Apr 26 | 2019Lispro AG Excluded from ESI 2019 Commercial Formulary Purchase Blast

sanofi cover image

Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal Apr 26 | 2019No Sotagliflozin CRL Clarity; Sanofi Q1 '19 Earnings Update Purchase Blast

astrazeneca cover image

Posted in: GLP-1RA, SGLT2i Apr 26 | 2019DECLARE Filing Accepted; AZ Q1 '19 Earnings Update Purchase Blast

lilly cover image

Posted in: Glucagon Apr 22 | 2019No Lilly Nasal Glucagon Update?Purchase Blast

novo cover image

Posted in: GLP-1RA Apr 18 | 2019Novo Oral Sema CVOT Initiated (SOUL)Purchase Blast

roche and abbott cover image

Posted in: Glucose Monitoring Apr 17 | 2019Abbott and Roche Q1 '19 Earnings Updates Purchase Blast

JnJ cover image

Posted in: SGLT2i Apr 16 | 2019JnJ Q1 '19 Earnings Update Purchase Blast

janssen cover image

Posted in: SGLT2i Apr 15 | 2019CREDENCE Demonstrates 30% RRR in Renal Outcomes; Nephros Likely New Priority Prescribers For Invokana Purchase Blast

novo cover image

Posted in: GLP-1RA Apr 10 | 2019New US Ozempic 3mL Pen Offering for Maintenance Dosing Purchase Blast

sanofi cover image

Posted in: Basal Insulin, Bolus Insulin Apr 10 | 2019New Sanofi Insulin Savings Program Purchase Blast

« prev 1 … 78 79 80 81 82 … 100 next »

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.

Contact BradyLog In